354 related articles for article (PubMed ID: 25204465)
1. Risk of QT/QTc prolongation among newer non-SSRI antidepressants.
Jasiak NM; Bostwick JR
Ann Pharmacother; 2014 Dec; 48(12):1620-8. PubMed ID: 25204465
[TBL] [Abstract][Full Text] [Related]
2. A comparison of the risk of QT prolongation among SSRIs.
Funk KA; Bostwick JR
Ann Pharmacother; 2013 Oct; 47(10):1330-41. PubMed ID: 24259697
[TBL] [Abstract][Full Text] [Related]
3. QTc prolongation, torsades de pointes, and psychotropic medications.
Beach SR; Celano CM; Noseworthy PA; Januzzi JL; Huffman JC
Psychosomatics; 2013; 54(1):1-13. PubMed ID: 23295003
[TBL] [Abstract][Full Text] [Related]
4. Antidepressants: their effects on cardiac channels, QT prolongation and Torsade de Pointes.
Sala M; Coppa F; Cappucciati C; Brambilla P; d'Allio G; Caverzasi E; Barale F; De Ferrari GM
Curr Opin Investig Drugs; 2006 Mar; 7(3):256-63. PubMed ID: 16555686
[TBL] [Abstract][Full Text] [Related]
5. Proarrhythmic risk with antipsychotic and antidepressant drugs: implications in the elderly.
Vieweg WV; Wood MA; Fernandez A; Beatty-Brooks M; Hasnain M; Pandurangi AK
Drugs Aging; 2009; 26(12):997-1012. PubMed ID: 19929028
[TBL] [Abstract][Full Text] [Related]
6. QTc interval prolongation and torsade de pointes associated with second-generation antipsychotics and antidepressants: a comprehensive review.
Hasnain M; Vieweg WV
CNS Drugs; 2014 Oct; 28(10):887-920. PubMed ID: 25168784
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for QT prolongation associated with acute psychotropic drug overdose.
Miura N; Saito T; Taira T; Umebachi R; Inokuchi S
Am J Emerg Med; 2015 Feb; 33(2):142-9. PubMed ID: 25445869
[TBL] [Abstract][Full Text] [Related]
8. Venlafaxine: more dangerous than most "selective" serotonergic antidepressants.
Prescrire Int; 2016 Apr; 25(170):96-9. PubMed ID: 27186622
[TBL] [Abstract][Full Text] [Related]
9. QT Prolongation, Torsades de Pointes, and Psychotropic Medications: A 5-Year Update.
Beach SR; Celano CM; Sugrue AM; Adams C; Ackerman MJ; Noseworthy PA; Huffman JC
Psychosomatics; 2018; 59(2):105-122. PubMed ID: 29275963
[TBL] [Abstract][Full Text] [Related]
10. Antipsychotic-related QTc prolongation, torsade de pointes and sudden death.
Haddad PM; Anderson IM
Drugs; 2002; 62(11):1649-71. PubMed ID: 12109926
[TBL] [Abstract][Full Text] [Related]
11. Azithromycin-induced proarrhythmia and cardiovascular death.
Howard PA
Ann Pharmacother; 2013 Nov; 47(11):1547-51. PubMed ID: 24285766
[TBL] [Abstract][Full Text] [Related]
12. QT alterations in psychopharmacology: proven candidates and suspects.
Alvarez PA; Pahissa J
Curr Drug Saf; 2010 Jan; 5(1):97-104. PubMed ID: 20210726
[TBL] [Abstract][Full Text] [Related]
13. Protease inhibitor-associated QT interval prolongation.
Hunt K; Hughes CA; Hills-Nieminen C
Ann Pharmacother; 2011 Dec; 45(12):1544-50. PubMed ID: 22128044
[TBL] [Abstract][Full Text] [Related]
14. Medical toxicologists' practice patterns regarding drug-induced QT prolongation in overdose patients: a survey in the United States of America, Europe, and Asia Pacific region.
Othong R; Devlin JJ; Kazzi ZN
Clin Toxicol (Phila); 2015 May; 53(4):204-9. PubMed ID: 25706450
[TBL] [Abstract][Full Text] [Related]
15. A new biomarker--index of cardiac electrophysiological balance (iCEB)--plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs).
Lu HR; Yan GX; Gallacher DJ
J Pharmacol Toxicol Methods; 2013; 68(2):250-259. PubMed ID: 23337247
[TBL] [Abstract][Full Text] [Related]
16. Arrhythmias related to antipsychotics and antidepressants: an analysis of the summaries of product characteristics of original products approved in Germany.
Elsayed M; Abdel-Kahaar E; Gahr M; Connemann BJ; Denkinger M; Schönfeldt-Lecuona C
Eur J Clin Pharmacol; 2021 May; 77(5):767-775. PubMed ID: 33230596
[TBL] [Abstract][Full Text] [Related]
17. Citalopram, QTc Prolongation, and Torsades de Pointes.
Tampi RR; Balderas M; Carter KV; Tampi DJ; Moca M; Knudsen A; May J
Psychosomatics; 2015; 56(1):36-43. PubMed ID: 25619672
[TBL] [Abstract][Full Text] [Related]
18. QTc Prolongation in Poison Center Exposures to CredibleMeds List of Substances with "Known Risk of Torsades de Pointes".
Ryan K; Benz P; Zosel A; Farkas A; Theobald J
Cardiovasc Toxicol; 2022 Sep; 22(9):866-877. PubMed ID: 35930218
[TBL] [Abstract][Full Text] [Related]
19. Tricyclic antidepressants, QT interval prolongation, and torsade de pointes.
Vieweg WV; Wood MA
Psychosomatics; 2004; 45(5):371-7. PubMed ID: 15345781
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of selective serotonin reuptake inhibitor-associated QTc prolongation.
Beach SR; Kostis WJ; Celano CM; Januzzi JL; Ruskin JN; Noseworthy PA; Huffman JC
J Clin Psychiatry; 2014 May; 75(5):e441-9. PubMed ID: 24922496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
